CULLINAN THERAPEUTICS, INC. (CGEM) Total liabilities 2020–2022
CULLINAN THERAPEUTICS, INC. (CGEM) total liabilities at each fiscal year-end, per SEC filings.
$26.1MFY2022 · since FY2020: $14.4M → $26.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $26.1M | +120.9% |
| FY2021 | $11.8M | -17.9% |
| FY2020 | $14.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CGEM financial trends
CGEM RevenueCGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Capital expendituresCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Shareholders’ equityCGEM overview →